• Home
  • Search Results
  • UV-responsive amphiphilic graft copolymers based on coumarin and polyoxazoline.

UV-responsive amphiphilic graft copolymers based on coumarin and polyoxazoline.

Soft matter (2017-06-07)
Laetitia Korchia, Vincent Lapinte, Christophe Travelet, Redouane Borsali, Jean-Jacques Robin, Cécile Bouilhac
ABSTRACT

A series of amphiphilic photo-responsive heterografted copolymers have been successfully synthesized. The random copolymers were composed of a methacrylate backbone, with various compositions of hydrophilic oligomeric 2-methyl-2-oxazoline side chains (OMOx) and hydrophobic long alkyl chains terminated by a coumarin moiety (Cm). Using dynamic (DLS) and static light scattering (SLS), and transmission electron microscopy (TEM), their self-assembling behavior was studied in water using the nanoprecipitation method. Depending on the system, one, two or three particle size distributions co-exist in solution. However, DLS measurements showed that monomodal and slightly polydisperse self-assemblies were obtained with the more hydrophobic copolymers (i.e., 85% of hydrophobic monomers with a long alkyl chain terminated by a coumarin moiety (MCm) per molecule) with hydrodynamic diameters ranging from ca. 130 to 300 nm. Morphological information on these self-assembly structures was obtained using SLS: a Gaussian behavior has thus been evidenced. Finally, these heterografted copolymers were illuminated using UV light at λ = 350 nm inducing photo-crosslinking of the coumarin units. The influence of UV illumination on the thus-formed nanoparticles was investigated by carrying out complementarily DLS-measurements and UV spectroscopy.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2-Methyl-2-oxazoline, 98%

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.